TY - JOUR
T1 - Photon Counting CT
T2 - Clinical Applications and Future Developments
AU - Hsieh, Scott S.
AU - Leng, Shuai
AU - Rajendran, Kishore
AU - Tao, Shengzhen
AU - McCollough, Cynthia H.
N1 - Funding Information:
Manuscript received June 4, 2020; revised August 15, 2020; accepted August 25, 2020. Date of publication August 28, 2020; date of current version July 2, 2021. This work was supported in part by the National Institutes of Health under Award R01 EB016966 and Award C06 RR018898, and in part by Siemens AG. (Corresponding author: Scott S. Hsieh.) The authors are with the Department of Radiology, Mayo Clinic, Rochester, MN 55905 USA (e-mail: hsieh.scott@mayo.edu; leng.shuai@mayo.edu; rajendran.kishore@mayo.edu; tao.shengzhen@mayo.edu; mccollough. cynthia@mayo.edu).
Publisher Copyright:
© 2017 IEEE.
PY - 2021/7
Y1 - 2021/7
N2 - The use of a photon counting detector in CT (PCD CT) is currently the subject of intense investigation and development. In this review article, we will describe potential clinical applications of this technology with a particular focus on the experience of our own institution with a prototype PCD CT scanner. Photon counting detectors (PCDs) have three primary advantages over conventional, energy integrating detectors (EIDs): 1) they provide spectral information without need for a dedicated dual-energy protocol; 2) they are immune to electronic noise; and 3) they can be made very high resolution without significant compromises to quantum efficiency. These advantages translate into several clinical applications. Metal artifacts, beam hardening artifacts, and noise streaks from photon starvation can be better mitigated using PCD CT. Certain incidental findings can be better characterized using the spectral information from PCD CT. High-contrast, high-resolution structures, such as the temporal bone can be better visualized using PCD CT and at greatly reduced dose. We also discuss new possibilities on the horizon, including new contrast agents, and how anticipated improvements in PCD CT will translate to performance in these applications.
AB - The use of a photon counting detector in CT (PCD CT) is currently the subject of intense investigation and development. In this review article, we will describe potential clinical applications of this technology with a particular focus on the experience of our own institution with a prototype PCD CT scanner. Photon counting detectors (PCDs) have three primary advantages over conventional, energy integrating detectors (EIDs): 1) they provide spectral information without need for a dedicated dual-energy protocol; 2) they are immune to electronic noise; and 3) they can be made very high resolution without significant compromises to quantum efficiency. These advantages translate into several clinical applications. Metal artifacts, beam hardening artifacts, and noise streaks from photon starvation can be better mitigated using PCD CT. Certain incidental findings can be better characterized using the spectral information from PCD CT. High-contrast, high-resolution structures, such as the temporal bone can be better visualized using PCD CT and at greatly reduced dose. We also discuss new possibilities on the horizon, including new contrast agents, and how anticipated improvements in PCD CT will translate to performance in these applications.
KW - Clinical applications
KW - photon counting X-ray detectors
KW - spectral CT
UR - http://www.scopus.com/inward/record.url?scp=85112682388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112682388&partnerID=8YFLogxK
U2 - 10.1109/TRPMS.2020.3020212
DO - 10.1109/TRPMS.2020.3020212
M3 - Review article
AN - SCOPUS:85112682388
SN - 2469-7311
VL - 5
SP - 441
EP - 452
JO - IEEE Transactions on Radiation and Plasma Medical Sciences
JF - IEEE Transactions on Radiation and Plasma Medical Sciences
IS - 4
M1 - 9179698
ER -